Yuhan Corp Preferred (KO:000105) — Market Cap & Net Worth
Market Cap & Net Worth: Yuhan Corp Preferred (000105)
Yuhan Corp Preferred (KO:000105) has a market capitalization of $45.29 Million (₩66.83 Billion) as of September 17, 2026. Listed on the KO stock exchange, this Korea-based company holds position #22349 globally and #1419 in its home market, demonstrating a -2.35% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yuhan Corp Preferred's stock price ₩58200.00 by its total outstanding shares 1148340 (1.15 Million). Also see Yuhan Corp Preferred (000105) total assets for a full breakdown of the balance sheet.
Yuhan Corp Preferred Market Cap History: 2015 to 2026
Yuhan Corp Preferred's market capitalization history from 2015 to 2026. Data shows growth from $17.65 Million to $52.06 Million (11.41% CAGR). Also see Yuhan Corp Preferred cash conversion from operations for how efficiently the company converts equity into cash flow.
Yuhan Corp Preferred Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yuhan Corp Preferred's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Yuhan Corp Preferred share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Yuhan Corp Preferred's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Yuhan Corp Preferred's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $17.16 Million | $1.32 Trillion | $161.25 Billion | 0.00x | 0.00x |
| 2017 | $21.72 Million | $1.46 Trillion | $109.03 Billion | 0.00x | 0.00x |
| 2018 | $23.17 Million | $1.52 Trillion | $57.48 Billion | 0.00x | 0.00x |
| 2019 | $26.88 Million | $1.48 Trillion | $40.01 Billion | 0.00x | 0.00x |
| 2020 | $48.18 Million | $1.62 Trillion | $192.76 Billion | 0.00x | 0.00x |
| 2021 | $43.30 Million | $1.69 Trillion | $102.58 Billion | 0.00x | 0.00x |
| 2022 | $42.49 Million | $1.78 Trillion | $95.14 Billion | 0.00x | 0.00x |
| 2023 | $49.42 Million | $1.86 Trillion | $136.20 Billion | 0.00x | 0.00x |
| 2024 | $80.86 Million | $2.07 Trillion | $70.69 Billion | 0.00x | 0.00x |
| 2025 | $78.83 Million | $2.19 Trillion | $194.08 Billion | 0.00x | 0.00x |
Competitor Companies of 000105 by Market Capitalization
Companies near Yuhan Corp Preferred in the global market cap rankings as of September 17, 2026. Review 000105 goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Yuhan Corp Preferred by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #519 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #633 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #640 globally with a market cap of $43.16 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.62 Billion USD ( CN¥277.61 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #519 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #633 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #640 | GALDERMA GROUP AG | NYSE:GALDY | $43.16 Billion | $37.02 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.62 Billion | CN¥43.52 |
Yuhan Corp Preferred Historical Marketcap From 2015 to 2026
Between 2015 and today, Yuhan Corp Preferred's market cap moved from $17.65 Million to $ 52.06 Million, with a yearly change of 11.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩52.06 Million | -33.96% |
| 2025 | ₩78.83 Million | -2.50% |
| 2024 | ₩80.86 Million | +63.62% |
| 2023 | ₩49.42 Million | +16.30% |
| 2022 | ₩42.49 Million | -1.86% |
| 2021 | ₩43.30 Million | -10.14% |
| 2020 | ₩48.18 Million | +79.24% |
| 2019 | ₩26.88 Million | +16.02% |
| 2018 | ₩23.17 Million | +6.66% |
| 2017 | ₩21.72 Million | +26.62% |
| 2016 | ₩17.16 Million | -2.81% |
| 2015 | ₩17.65 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 11th, 2026 the market cap of Yuhan Corp Preferred was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $45.29 Million USD |
| MoneyControl | $45.29 Million USD |
| MarketWatch | $45.29 Million USD |
| marketcap.company | $45.29 Million USD |
| Reuters | $45.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Yuhan Corp Preferred
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and ana… Read more